State Street’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,527,235
| Closed | -$23.5M | – | 4522 |
|
|
2023
Q3 | $23.5M | Buy |
3,527,235
+131,083
| +4% | +$874K | ﹤0.01% | 2066 |
|
|
2023
Q2 | $30.8M | Buy |
3,396,152
+274,757
| +9% | +$2.49M | ﹤0.01% | 1966 |
|
|
2023
Q1 | $22.7M | Sell |
3,121,395
-1,164,862
| -27% | -$8.47M | ﹤0.01% | 2139 |
|
|
2022
Q4 | $31.2M | Buy |
4,286,257
+1,277,089
| +42% | +$9.31M | ﹤0.01% | 1935 |
|
|
2022
Q3 | $23.3M | Buy |
3,009,168
+791,372
| +36% | +$6.12M | ﹤0.01% | 2110 |
|
|
2022
Q2 | $15.1M | Buy |
2,217,796
+1,947,859
| +722% | +$13.3M | ﹤0.01% | 2441 |
|
|
2022
Q1 | $2.15M | Buy |
269,937
+17,245
| +7% | +$137K | ﹤0.01% | 3536 |
|
|
2021
Q4 | $1.42M | Buy |
252,692
+26,292
| +12% | +$147K | ﹤0.01% | 3736 |
|
|
2021
Q3 | $1.74M | Buy |
+226,400
| New | +$1.74M | ﹤0.01% | 3644 |
|